Rich Christopher Email and Phone Number
Rich Christopher work email
- Valid
- Valid
- Valid
- Valid
Rich Christopher personal email
Rich Christopher phone numbers
Results oriented pharmaceutical and medical device executive with proven success in a dynamic, high growth environment. Established track record in leading a pharmaceutical “start-up” from its operational infancy, through commercial profitability, to its eventual sale.
-
Chief Executive OfficerLexaria Bioscience Sep 2024 - PresentKelowna, British Columbia, CaLexaria Bioscience Corp. (Nasdaq: LEXX) is a global innovator in drug delivery platforms. It's patented drug delivery formulation and processing technology, DehydraTECH, improves the way in which active pharmaceutical ingredients enter the bloodstream. Lexaria is currently focused on the advancement and improvement of drug delivery in the GLP-1 and hypertension marketplaces.
-
Chief Financial OfficerInvivo Therapeutics Jan 2019 - Jul 2024Cambridge, Ma, UsInVivo Therapeutics is a pioneering biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries. Our goal is to develop and commercialize groundbreaking technologies and treatments for spinal cord injury (SCI). Currently, there are no treatment options to provide meaningful improvement in patient outcomes following SCI. At the core of InVivo’s technology portfolio is the Neuro-Spinal ScaffoldTM, a novel and proprietary biomaterial that is implanted into the epicenter of the injury to modulate the healing environment and serve as a support for neuroregeneration. InVivo intends to develop its novel Neuro-Spinal Scaffold to treat acute SCI, and its Bioengineered Neural TrailsTM (injectable combinations of biomaterials and neural stem cells) to treat chronic SCI. -
Executive Vice President & Chief Financial OfficerIcad Dec 2016 - Jan 2019Nashua, Nh, UsiCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and while enhancing patient care. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked for use anywhere in the body, including treatment of non-melanoma skin cancer, early-stage breast cancer and gynecological cancers. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. -
Chief Financial & Operating OfficerCaliber Imaging & Diagnostics, Inc. Mar 2014 - Dec 2016Rochester, Ny, UsCaliber I.D. is a medical technologies company that designs, develops, and markets innovative imaging solutions that shows tissue at the cellular level. It is the only company in the world to offer in vivo confocal microscopes designed specifically for imaging skin and other tissue. Caliber's Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye. Caliber I.D. has developed the VivaScope, a robust suite of imaging products. The VivaScope suite offers breakthrough technology that represents a new era in medical imaging. Physicians now have a cellular-level view of the patient's skin at the bedside, allowing for immediate tissue characterization and treatment. For those cases that require additional support from other specialists, Caliber I.D.'s telepathology system allows near real-time collaboration with remote specialists. -
Vp Finance & CfoDusa Pharmaceuticals, Inc. Dec 2000 - Apr 2013Wilmington, Massachusetts, UsDUSA Pharmaceuticals, Inc. is a vertically integrated specialty dermatology company focused primarily on the development and marketing of its Levulan® Photodynamic Therapy (PDT) technology platform for the treatment of precancerous skin lesions (actinic keratoses or AK). PDT is a drug/device combination therapy which utilizes a proprietary light source to activate a photosensitive drug. DUSA, a formerly publicly traded company on NASDAQ (symbol: DUSA), was acquired by Sun Pharmaceuticals Industries Limited in December of 2012.
Rich Christopher Skills
Rich Christopher Education Details
-
Bentley UniversityFinance -
Suffolk UniversityAccounting
Frequently Asked Questions about Rich Christopher
What company does Rich Christopher work for?
Rich Christopher works for Lexaria Bioscience
What is Rich Christopher's role at the current company?
Rich Christopher's current role is Chief Executive Officer at Lexaria Bioscience Corp..
What is Rich Christopher's email address?
Rich Christopher's email address is ch****@****rma.com
What is Rich Christopher's direct phone number?
Rich Christopher's direct phone number is +158523*****
What schools did Rich Christopher attend?
Rich Christopher attended Bentley University, Suffolk University.
What skills is Rich Christopher known for?
Rich Christopher has skills like Medical Devices, Mergers And Acquisitions, Pharmaceutical Industry, Start Ups, Forecasting, Financial Analysis, Cross Functional Team Leadership, Strategic Planning, Strategy, Budgets, Financial Modeling, Sales.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial